DEA Archived Press Releases

Press Releases before January 20, 2025
872 Results - Showing 361 to 370
PRESS RELEASE

DEA and FDA warn website operators illegally offering opioids for sale

WASHINGTON – The U.S. Drug Enforcement Administration and the U.S. Food and Drug Administration have issued warning letters to four website owners of rogue online pharmacies offering to distribute or dispense controlled substances, including opioids, and advertising their sale in violation of federal law. This is the first time the...
PRESS RELEASE

Federal health care fraud takedown in Northeastern U.S. results in 54 defendants charged and convicted

NEWARK, N.J. – The Justice Department today announced a coordinated health care fraud enforcement action across seven federal districts in the Northeastern United States, involving more than $800 million in losses and the distribution of over 3.25 million pills of opioids in “pill mill” clinics and doctors’ offices. The takedown...
PRESS RELEASE

Atlantic City woman charged with drug distribution resulting in death

NEWARK, N.J. – Special Agent in Charge of the Drug Enforcement Administration’s New Jersey Division Susan A. Gibson, and U.S. Attorney for the District of New Jersey, Craig Carpenito, announced an Atlantic City, New Jersey, woman was indicted today on charges including drug distribution that resulted in a death. Rajeri...
PRESS RELEASE

DEA proposes to control three precursor chemicals used to illicitly manufacture deadly fentanyl

WASHINGTON – In an effort to reduce the availability of deadly illegal fentanyl in America, the U.S. Drug Enforcement Administration has proposed to control three substances used by operators of clandestine laboratories to illicitly manufacture the deadly Schedule II controlled substance. Two Notices of Proposed Rulemaking were published in the...
PRESS RELEASE

DEA proposes to reduce the amount of five opioids manufactured in 2020, marijuana quota for research increases by almost a third

WASHINGTON – The U.S. Drug Enforcement Administration is proposing to reduce the amount of five Schedule II opioid controlled substances that can be manufactured in the United States next year compared with 2019, per the Notice of Proposed Rulemaking being published in the Federal Register tomorrow and available for public...
PRESS RELEASE

DEA announces steps necessary to improve access to marijuana research

WASHINGTON – The Drug Enforcement Administration today announced that it is moving forward to facilitate and expand scientific and medical research for marijuana in the United States. The DEA is providing notice of pending applications from entities applying to be registered to manufacture marijuana for researchers. DEA anticipates that registering...
PRESS RELEASE

New Jersey nurse charged with drug and weapons offenses

NEWARK, N.J. – Special Agent in Charge of the Drug Enforcement Administration’s New Jersey Division Susan A. Gibson, Prosecutor of Ocean County Bradley D. Billhimer, and Jackson Township Chief of Police Matthew Kunz announced a nurse was charged with several drug and weapons charges in Jackson, New Jersey. Anthony A...
PRESS RELEASE

Lebanese businessman tied by Treasury Department to Hezbollah is sentenced to prison for money laundering scheme involving the evasion of U.S. sanctions

WASHINGTON – The operator of a network of businesses in Lebanon and Africa, whom the United States Department of the Treasury designated as a financier of Lebanon-based terrorist group Hezbollah, was sentenced to five years in prison and ordered to forfeit $50 million by U.S. District Judge Reggie B. Walton...
PRESS RELEASE

Former Honduran drug trafficker sentenced to life in prison for distributing over 150 tons of controlled substances

NEW YORK – DEA Special Operations Division Acting Special Agent in Charge Michael Machak and United States Attorney for the Southern District of New York Geoffrey S. Berman announced today that Hector Emilio Fernandez Rosa, aka “Don H,” was sentenced to life in prison for conspiring to distribute and possess...
PRESS RELEASE

Twelve people charged in long-running investigation of Newark G-Shine Bloods

NEWARK, N.J. – DEA New Jersey Division Special Agent in Charge Susan A. Gibson and U.S. Attorney for the District of New Jersey Craig Carpenito announced 12 members, associates and suppliers of a drug trafficking organization based in Newark have been charged in connection with their roles in distributing heroin...